Biotech Breakthroughs

Results

56

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

56 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	MDGL	US$528.10	3.0%	76.7%	US$12.2b	US$678.71	10.8	59.2%	n/a	Pharmaceuticals & Biotech
	SNDX	US$21.82	2.4%	142.4%	US$1.9b	US$39.00	8.9	68.2%	n/a	Pharmaceuticals & Biotech
	ARDX	US$5.27	-5.0%	23.4%	US$1.3b	US$16.30	3.0	55.9%	n/a	Pharmaceuticals & Biotech
	MRKR	US$1.47	11.8%	-8.1%	US$24.5m	US$7.87	6.9	69.0%	n/a	Pharmaceuticals & Biotech
	TNYA	US$0.79	9.7%	28.6%	US$170.8m	US$4.00	758.9	60.9%	n/a	Pharmaceuticals & Biotech
	CAPR	US$23.21	-12.2%	126.4%	US$1.3b	US$53.60	4.8	64.2%	n/a	Pharmaceuticals & Biotech
	ACHV	US$6.40	6.3%	193.6%	US$657.0m	US$13.80	61.5	64.3%	n/a	Pharmaceuticals & Biotech
	NTLA	US$17.56	5.3%	63.5%	US$2.5b	US$26.63	37.1	67.0%	n/a	Pharmaceuticals & Biotech
	ALDX	US$2.27	24.0%	-47.2%	US$136.9m	US$7.60	3.2	65.2%	n/a	Pharmaceuticals & Biotech
	LCTX	US$1.35	5.5%	33.7%	US$336.6m	US$5.50	22.8	72.3%	n/a	Pharmaceuticals & Biotech
	RNXT	US$0.92	-2.5%	-32.3%	US$41.5m	US$7.03	27.9	73.0%	n/a	Pharmaceuticals & Biotech
	FRMM	US$6.02	7.9%	-31.6%	US$79.5m	US$9.50	8.5	127.7%	n/a	Pharmaceuticals & Biotech
	VRDN	US$19.40	8.4%	23.8%	US$2.1b	US$36.13	30.2	60.9%	n/a	Pharmaceuticals & Biotech
	ACIU	US$2.51	-2.0%	21.3%	US$249.0m	US$8.51	54.1	54.4%	n/a	Pharmaceuticals & Biotech
	HUMA	US$0.71	0.2%	-68.9%	US$191.4m	US$2.05	95.0	60.9%	n/a	Pharmaceuticals & Biotech
	CGON	US$70.36	-2.2%	161.6%	US$6.2b	US$90.29	1223.8	60.1%	n/a	Pharmaceuticals & Biotech
	LGVN	US$0.69	-3.5%	-47.3%	US$21.5m	US$7.15	17.7	55.5%	n/a	Pharmaceuticals & Biotech
	ARQT	US$25.81	-4.4%	86.8%	US$3.2b	US$34.63	7.8	48.5%	n/a	Pharmaceuticals & Biotech
	CTOR	US$0.68	9.7%	-87.1%	US$63.3m	US$4.00	11.3	59.9%	n/a	Pharmaceuticals & Biotech
	NAMS	US$34.83	4.8%	75.5%	US$4.1b	US$49.62	180.4	65.3%	n/a	Pharmaceuticals & Biotech
	VERA	US$41.20	-3.0%	71.7%	US$3.0b	US$78.00	5.9	64.5%	n/a	Pharmaceuticals & Biotech
	LRMR	US$3.26	-10.9%	1.9%	US$340.3m	US$14.40	2.2	52.5%	n/a	Pharmaceuticals & Biotech
	INSM	US$111.60	8.0%	14.1%	US$24.2b	US$197.05	29.5	67.2%	n/a	Pharmaceuticals & Biotech
	MNOV	US$1.43	8.3%	14.4%	US$70.4m	US$9.00	118.0	66.7%	n/a	Pharmaceuticals & Biotech

Page 1 of 2